REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Csapi Geza Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Dr. CSAPI GEZA Gyogyszerkereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Dr. Csapi Geza Bt. is a company in Hungary, with a head office in Kecel. It operates in the Pharmacies and Drug Stores industry. It was established on June 01, 1997. It currently has a total number of 11 (2024) employees. In 2023, the company reported a net sales revenue increase of 11.21%. Its’ total assets recorded a negative growth of 10.22%. Dr. Csapi Geza Bt.’s net profit margin decreased by 2.17% in 2023.

Headquarters
Rakoczi F. u. 1.
Kecel; Bacs-Kiskun; Postal Code: 6237

Contact Details: Purchase the Dr. Csapi Geza Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Dr. Csapi Geza Bt. report to view the information.
Outstanding Shares:
Purchase the Dr. Csapi Geza Bt. report to view the information.
Registered Capital:
Purchase the Dr. Csapi Geza Bt. report to view the information.
Incorporation Date:
June 01, 1997
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Csanad Pharma Kft.
Company Performance
Financial values in the chart are available after Dr. Csapi Geza Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
11.21%
Total operating revenue
10.78%
Operating profit (EBIT)
-46.56%
EBITDA
-38.64%
Net Profit (Loss) for the Period
-46.87%
Total assets
-10.22%
Total equity
-9.06%
Operating Profit Margin (ROS)
-2.37%
Net Profit Margin
-2.17%
Return on Equity (ROE)
-8.02%
Quick Ratio
-0.17%
Cash Ratio
-0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?